Cell And Gene Therapy Manufacturing Services Global Market Opportunities And Strategies To 2033

Description

Cell and gene therapy manufacturing services represent a pioneering sector within the biopharmaceutical industry, dedicated to the production of innovative treatments that modify the genetic material of individuals or use living cells to treat or prevent disease.

Cell therapy involves the transfer of cells with the relevant function into a patient, often aiming to restore or establish normal cell function, replacing damaged or absent cells. Gene therapy, on the other hand, involves altering the genetic material within a patient's cells to treat or prevent disease, offering potential cures for a wide range of genetic and acquired diseases.

The global cell and gene therapy manufacturing services market was valued at $3,860.06 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 12.0%.

Rising Autoimmune Diseases

During the historic period, an increasing incidence of autoimmune disease supported the growth of the cell and gene therapy manufacturing services market. Autoimmune disease refers to conditions in which the immune system mistakenly attacks the body's cells, tissues, or organs, leading to inflammation and dysfunction. The increasing incidence of autoimmune disorders is attributed to a combination of genetic predisposition, environmental factors and lifestyle changes. Cell and gene therapy manufacturing services are crucial in developing precision therapies for autoimmune diseases, providing targeted treatments to modulate the immune system with improved efficacy and safety.

For instance, in May 2023, according to the University of Oxford, a UK-based research university, about 10% of people have autoimmune diseases. Among them, 13% are women and 7% are men. This is higher than previous estimates, which were between 3% and 9%. Therefore, the increasing incidence of autoimmune disease positively impacted the growth of the cell and gene therapy manufacturing services market during the historic period.

Development Of Next-Generation CAR T Therapies

Cell and gene therapy manufacturing services companies are focusing on the development and recruitment of clinical trials for "off-the-shelf" allogeneic cell therapy to improve CAR T therapies. For instance, in October 2022, Allogene Therapeutics, a US-based clinical-stage biotechnology company, launched the CAR T Together initiative, a pioneering effort that unites prominent oncologists from esteemed research institutions nationwide. CAR T Together is working to improve CAR T therapies by creating allogeneic options. These come from donors, making them ready to use and easy to produce in large quantities.

The global cell and gene therapy manufacturing services market is highly concentrated, with a small number of large players dominating the market. The top ten competitors in the market made up 52.01% of the total market in 2022.

Cell And Gene Therapy Manufacturing Services Global Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cell and gene therapy manufacturing services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cell and gene therapy manufacturing services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy manufacturing services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cell and gene therapy manufacturing services market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by indication, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the cell and gene therapy manufacturing services market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by indication, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
Competitive Dashboard - Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations - This section includes recommendations for cell and gene therapy manufacturing services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Gene Therapy; Cell Therapy
2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases; Metabolic Diseases; Other Diseases
3) By Application: Commercial Manufacturing; Clinical Manufacturing
4) By End-User: Academic and Research Institutes; Pharmaceutical and Biotechnology Companies; Other End-Users
Companies Mentioned: Thermo Fisher Scientific, Inc.; Merck KGaA; F. Hoffmann-La Roche Ltd; Charles River Laboratories International Inc.; Catalent Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cell and gene therapy manufacturing services indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1147

1 Executive Summary

1.1 Cell And Gene Therapy Manufacturing Services - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Cell And Gene Therapy Manufacturing Services Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Gene Therapy
- 6.4.2 Cell Therapy
6.5 Market Segmentation By Indication
- 6.5.1 Central Nervous System Disorders
- 6.5.2 Ophthalmology Diseases
- 6.5.3 Cardiovascular Diseases
- 6.5.4 Infectious Diseases
- 6.5.5 Orthopedic Diseases
- 6.5.6 Oncology Diseases
- 6.5.7 Metabolic Diseases
- 6.5.8 Other Diseases
6.6 Market Segmentation By Application
- 6.6.1 Commercial Manufacturing
- 6.6.2 Clinical Manufacturing
6.7 Market Segmentation By End-User
- 6.7.1 Academic And Research Institutes
- 6.7.2 Pharmaceutical And Biotechnology Companies
- 6.7.3 Other End-Users

7 Cell And Gene Therapy Manufacturing Services Market - Macro Economic Scenario

7.1 COVID-19 Impact On The Cell And Gene Therapy Manufacturing Services Market
7.2 Impact Of The War In Ukraine On The Cell And Gene Therapy Manufacturing Services Market
7.3 Impact Of High Inflation On The Cell And Gene Therapy Manufacturing Services Market

8 Major Market Trends

8.1 Strategic Investments To Expand Manufacturing Capacities
8.2 Strategic Collaborations For Advancing Cancer Treatment Production Processes
8.3 Development Of Next-Generation CAR T Therapies
8.4 Enhancement In Cell And Gene Therapy Manufacturing With Innovative Technologies
8.5 Innovative Solutions Driving Efficiency In Cell And Gene Therapy Manufacturing

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Cell And Gene Therapy Manufacturing Services Market Segmentation

10.1 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Cell And Gene Therapy Manufacturing Services Market, Regional and Country Analysis

11.1 Global Cell And Gene Therapy Manufacturing Services Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Cell And Gene Therapy Manufacturing Services Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.2 65
- 12.1.3 65
- 12.1.4 65
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 77
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.2 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Cell And Gene Therapy Manufacturing Services Market: Country Analysis
13.6 UK Market
13.7 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
14.2 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Cell And Gene Therapy Manufacturing Services Market: Country Analysis
14.6 Russia Market
14.7 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Cell And Gene Therapy Manufacturing Services Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Cell And Gene Therapy Manufacturing Services Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 Thermo Fisher Scientific Inc.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial performance
19.3 Merck KGaA
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 F. Hoffman-La Roche Ltd.
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Charles River Laboratories International Inc.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial overview
19.6 Catalent Inc
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 QHP Capital Acquired Applied StemCell Inc.
22.2 Fujifilm Corporation Acquired Atara Biotherapeutics Inc.
22.3 Thermo Fisher Scientific Inc. Acquired PeproTech, Inc.
22.4 Charles River Laboratories International, Inc. Acquired Vigene Biosciences, Inc.
22.5 Thermo Fisher Scientific Inc. Acquired Henogen SA

23 Future Outlook and Potential Analysis

23.1 Global Cell And Gene Therapy Manufacturing Services Market In 2028 - Countries Offering Most New Opportunities
23.2 Global Cell And Gene Therapy Manufacturing Services Market In 2028 - Segments Offering Most New Opportunities
23.3 Global Cell And Gene Therapy Manufacturing Services Market In 2028 - Growth Strategies
- 23.3.1 Market Trend Based Strategies
- 23.3.2 Competitor Strategies

24 Appendix

24.1 Geographies Covered
24.2 Market Data Sources
24.3 Research Methodology
24.4 Currencies
24.5 The Business Research Company
24.6 Copyright and Disclaimer